Co-Authors
This is a "connection" page, showing publications co-authored by Yunbao Pan and Fuling Zhou.
Connection Strength
2.487
-
Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia. Front Pharmacol. 2017; 8:359.
Score: 0.720
-
Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study. Virulence. 2020 12; 11(1):1569-1581.
Score: 0.229
-
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey. EClinicalMedicine. 2020 Sep; 26:100510.
Score: 0.226
-
Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial. Evid Based Complement Alternat Med. 2019; 2019:8796234.
Score: 0.203
-
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway. J Exp Clin Cancer Res. 2018 Nov 19; 37(1):277.
Score: 0.199
-
Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer. Front Pharmacol. 2018; 9:135.
Score: 0.189
-
A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia. Sci Rep. 2018 01 10; 8(1):294.
Score: 0.187
-
DNA methylation profiles in cancer diagnosis and therapeutics. Clin Exp Med. 2018 Feb; 18(1):1-14.
Score: 0.182
-
Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress. Clin Cancer Res. 2017 Aug 01; 23(15):4450-4461.
Score: 0.177
-
Current treatment options of T cell-associated immunotherapy in multiple myeloma. Clin Exp Med. 2017 Nov; 17(4):431-439.
Score: 0.175